Currently there are six (6) individual patents issued by the United States Patent Office for AC-11бу: U.S. Patent Nos. 6,039,949, 6,238,675 B1, 6,964,784 B2, 6,361,805 B2, 7,579,023 B2 and 7,595,064 B2. Our portfolio of patents covers manufacturing, composition and claims, including specifically the patented AC-11бу claim for DNA repair. Additional domestic and foreign patent applications are pending.

AC-11бу is manufactured and sold in powdered form, either for ingestible use as a stand-alone dietary supplement or in combination formulas with vitamins, minerals and other nutritional supplements, or for topical application in any number of cosmetic and cosmeceutical products. AC-11бу is registered as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA) and listed under its INCI (International Nomenclature of Cosmetics Ingredients) names Maltodextrin and C1-8 Alkyl Tetrahydroxycyclohexanoate with the Personal Care Products Council (formerly the Cosmetic, Toiletry and Fragrance Association or CTFA). AC-11бу moreover is approved for sale in numerous foreign countries.